Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

NIOSH grants Noveko N95 certification for RD5-V respirator

Noveko International Inc. is pleased to announce that its subsidiary Noveko Inc. has obtained N95 certification from the U.S. National Institute for Occupational Safety and Health ("NIOSH") for its Noveko RD5-V respirator.

10 Jun 2011

Patheon second quarter revenues decrease 3.1% to $170.0 million

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today financial results for the second quarter ended April 30, 2011.

10 Jun 2011

Chinese medical devices market to achieve revenues of $30.6B by 2017

The Chinese medical devices market has enjoyed rapid growth of late and is forecast to achieve revenues of $30.6 billion by 2017, according to a report released on companiesandmarkets.com.

10 Jun 2011

Masimo receives GOLD 2011 Medical Design Excellence Award for Pronto-7 noninvasive hemoglobin

Masimo Corporation announced today that its Pronto-7 handheld noninvasive hemoglobin, arterial oxygen saturation (SpO2), pulse rate, and perfusion index spot-check testing device has received the GOLD 2011 Medical Design Excellence Award—the highest award given in the general hospital devices and therapeutic products category.

10 Jun 2011

Accuray receives shareholders approval to acquire TomoTherapy

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated by Accuray.

10 Jun 2011

Respira introduces breakthrough Dry Powder Inhaler

Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, introduces the company's Dry Powder Inhaler (DPI) as a breakthrough solution for the pharmaceutical industry. Based on proprietary drug engine technology (DET), Respira Therapeutics' DPI significantly improves therapeutic performance and enables addressing the unmet medical needs of patients with severe respiratory diseases.

9 Jun 2011

University of Mississippi grants ChromaDex global rights to pterostilbene

ChromaDex Corp. and the University of Mississippi today announced the university has granted the natural products company the exclusive worldwide patent rights to a potential new therapeutic use for pterostilbene (tero-STILL-bean) as an anxiolytic or anti-anxiety agent. ChromaDex' pTeroPure® is an ultra-pure formulation of pterostilbene, a compound found in blueberries and demonstrated to have multiple health benefits.

9 Jun 2011

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Repligen Corporation today reported results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

9 Jun 2011

UAB acquires first cell-processing workstation from SANYO

The University of Alabama at Birmingham has taken a significant step toward making sophisticated cell therapy a part of patient care with its acquisition of the first cell-processing workstation (CPWS) from SANYO North America Corporation (SANYO) in the United States.

9 Jun 2011

New grade of polycarbonate meets growing trend for thinner walls in medical devices

As demand for smaller, less intrusive medical devices continues to grow, designers and OEMs are increasingly seeking materials with properties that can make these new devices possible. Bayer MaterialScience LLC is launching a new grade of medical polycarbonate to address this need during the Medical Design & Manufacturing East conference, taking place at the Jacob K. Javits Convention Center in New York City, June 6-9.

8 Jun 2011

UAB first in U.S. with cell-processing workstation

8 Jun 2011

Conference panel examines manufacturing of nutrition-rich foods

IRIN reports on a World Conference on Humanitarian Studies panel discussion about the manufacturing of nutrition-rich foods to treat malnutrition in the developing world.

8 Jun 2011

Vaccine candidate produces immune response to antigen in all strains of influenza A

A universal influenza vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu vaccine annually to match predicted strains, with major implications for global health.

8 Jun 2011

RF Industries second quarter net sales increase 16% to $4,392,000

RF INDUSTRIES, LTD. today announced that for the period ended April 30, 2011, net income increased 23% to $407,000, or $0.06 per diluted share, compared to $330,000, or $0.05 per diluted share, in the second quarter last year. Net sales increased 16% to $4,392,000, compared to $3,778,000 in the same period last year.

7 Jun 2011

Simcere announces settlement agreement with former Jiangsu Quanyi shareholders

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that a settlement agreement with certain former shareholders and directors of Jiangsu Quanyi Biological Technology Stock Co., Ltd. has become effective.

7 Jun 2011

Proteus, Avery Dennison partner for patch-based wearable sensors

Avery Dennison Medical Solutions, a division of Avery Dennison Corporation and a global leader in pressure-sensitive adhesive technologies for medical applications, in cooperation with Proteus Biomedical, Inc., a leader in intelligent medicine and mobile health products, today announced a partnership focusing on patch-based wearable sensors for consumer, home health care and remote medical applications.

7 Jun 2011

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

BioSante Pharmaceuticals, Inc. today announced that the FDA's clinical hold on the GVAX Prostate Cancer Vaccine for the treatment of prostate cancer has been lifted by FDA.

7 Jun 2011

AstraZeneca receives AmeriCares' Power of Partnership Award for global health programs

AmeriCares has awarded its annual Power of Partnership Award to AstraZeneca for its outstanding commitment to increasing access to health care for people in need both here at home and throughout the developing world.

7 Jun 2011

TenX BioPharma grants Emergent BioSolutions rights to zanolimumab

Emergent BioSolutions Inc. announced today that it has acquired from TenX BioPharma, Inc. the rights to zanolimumab, an investigational, late-stage monoclonal antibody cancer therapy targeting T-cell lymphomas.

6 Jun 2011

Crystal Research Associates report now available in MedPro website

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced the availability of a recently published research report prepared for the Company by Crystal Research Associates.

6 Jun 2011